Literature DB >> 7037982

A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results.

M H Wahdan, C Sérié, Y Cerisier, S Sallam, R Germanier.   

Abstract

A controlled field trial of Salmonella typhi strain Ty 21a oral vaccine against typhoid was carried out in Alexandria, Egypt, from March 1978 to March 1981. A total of 32,388 children was included in the study. The children were divided in two comparable groups, one given three doses of vaccine and the other three doses of placebo. Each dose of vaccine contained 1-8 X 10(9) live Ty 21a bacteria. The population was monitored, and each suspected case of typhoid was investigated bacteriologically and serologically. The effectiveness of the vaccine was assessed by analyzing the number of confirmed cases of typhoid fever in the two groups. The incidence of typhoid fever was 4.9 cases per 10,000 children per year in the control group and 0.2 cases per 10,000 children per year in the vaccine group. The results indicate that, in the dose schedule used, the Ty 21a mutant strain, which is stable and safe, is protective for a period of at least three years.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037982     DOI: 10.1093/infdis/145.3.292

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  68 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.

Authors:  J Y Wang; M F Pasetti; F R Noriega; R J Anderson; S S Wasserman; J E Galen; M B Sztein; M M Levine
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Typhoid Fever-;recherches du temps perdu'.

Authors:  S L Gorbach
Journal:  West J Med       Date:  1986-05

4.  Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Soo-Young Wanda; Cheryl A Nickerson; Roy Curtiss
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

5.  Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions.

Authors:  J R Murphy; S S Wasserman; S Baqar; L Schlesinger; C Ferreccio; A A Lindberg; M M Levine
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 6.  Oral vaccination against enteric bacterial infections: an overview.

Authors:  R Germanier
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

7.  Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever.

Authors:  B Hirschel; R Wüthrich; B Somaini; R Steffen
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

8.  Some galE mutants of Salmonella choleraesuis retain virulence.

Authors:  N A Nnalue; B A Stocker
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

Review 9.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

10.  Estimating the incidence of typhoid fever and other febrile illnesses in developing countries.

Authors:  John A Crump; Fouad G Youssef; Stephen P Luby; Momtaz O Wasfy; Josefa M Rangel; Maha Taalat; Said A Oun; Frank J Mahoney
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.